1910 logo

1910

Multimodal AI Platform for Modality Agnostic Drug Discovery™

Winter 2019Healthcare / Healthcare -> TherapeuticsBoston, MA, USA20 employees
AI-powered Drug Discovery

About

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

Founders (1)

Jen Asher
Founder & CEO

Details

Status
Active
Stage
Growth
Team Size
20
Regions
United States of America, America / Canada